13th Annual International Symposium on Ovarian Cancer 2022

The 13th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™ is not to be missed!

The 13th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™ is a 1-day, educational and scientific meeting that will focus on key clinical topics in the management of ovarian cancer as well as endometrial and cervical malignancies.

Join leading experts as they debate and discuss the latest diagnostic, therapeutic, and supportive care strategies for patients with gynecologic cancers. Management of gynecologic malignancies is a dynamic field with recent advances shifting the treatment paradigm to provide significant clinical benefit for patients. Optimal implementation of chemotherapy, targeted therapies, immunotherapies, and combination and other therapeutic strategies, will be analyzed and discussed both in frontline and relapsed disease settings. Case-based presentations will allow for vibrant discussion of the practical concerns of treating patients in the real world. Promising novel agents undergoing clinical trial evaluation also will be highlighted.

This highly practical and interactive symposium will provide a unique opportunity for medical oncologists, as well as other health care professionals, to learn from and interact with world-renowned experts in the field of gynecologic malignancies. The goal of this conference is to increase clinical knowledge among participants, foster the application of new data into practice, and, ultimately, to improve patient outcomes. We encourage you to join us.

The learning objectives of this program are:

• Discuss the current and emerging roles for germline and somatic testing in newly diagnosed and recurrent ovarian cancers;
• Outline the current and emerging role of PARP inhibitor therapy in gynecological malignancies with a focus on ovarian cancer;
• Review the rationale supporting the role of immunotherapy in gynecologic malignancies with a focus on cervical and endometrial cancers; and
• Integrate recent data and emerging trends into clinical context and analyze their therapeutic implications in the management of gynecologic malignancies.

The target audience for this activity is medical oncologists and fellows who treat patients with gynecologic malignancies. Gynecologic oncologists, surgical oncologists, radiation oncologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of gynecologic malignancies will be invited to participate.

What You'll Experience

The important benefits of attending this congress includes:

• Learn from and interact with world-renowned experts to expand your knowledge in the field of gynecologic malignancies;
• Hear a debate-style presentation featuring 2 experts—each offering opposing viewpoints on the treatment options for Homologous Recombination–Proficient (HRP) Ovarian Cancer—and weigh in on who you think has the most persuasive argument;
• Gain insight into how experts treat patients with gynecologic malignancies through several case-based, interactive presentations and discussions;
• Participate in a dedicated session led by national/international experts to discuss the revolutionary impact that immunotherapies are having in the treatment of ovarian, cervical, and endometrial cancer; and
• Have your most pressing clinical questions answered during the numerous Q & A sessions throughout the conference.